FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Breckenridge Pharmaceutical Zoledronic Acid Injection 5 mg/100 mL Recall

Zoledronic Acid Injection 5 mg/100 mL (0

Breckenridge Pharmaceutical, Inc · Berlin, CT

Risk level
Class III
Reported by FDA
Mar 4, 2020
Recall ID
D-1063-2020
Check your lot numberHow we source this data

Summary

Breckenridge Pharmaceutical recalled Zoledronic Acid Injection 5 mg/100 mL starting Feb 24, 2020. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-1063-2020 on Mar 4, 2020. Reason: Failed Impurities/Degradation Specifications: Out-of-specification results obtained for impurities during stability testing. Status: Terminated.

Why it was recalled

Failed Impurities/Degradation Specifications: Out-of-specification results obtained for impurities during stability testing.

Product description

Zoledronic Acid Injection 5 mg/100 mL (0.05 mg/mL), Solution for Intravenous Infusion, Sterile Solution, 100 mL Single - Dose Vial per Carton, Rx Only, Distributed by: Breckenridge Pharmaceutical, Inc., Boca Raton, FL 33487, Manufactured by: Pharmaceutics International, Inc., Hunt Valley, MD 21031, NDC 51991-064-98.

Lot numbers, UPCs & expiration codes

Lot # 5553.044E; 5553.044F, Exp. 04/30/2021

Where it was sold

Nationwide in the U.S.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1063-2020
Classification
Class III
Status
Terminated
Recall initiated
Feb 24, 2020
FDA report date
Mar 4, 2020
Quantity
900 Vials
Recall type
Voluntary: Firm initiated
Recalling firm
Breckenridge Pharmaceutical, Inc

Original FDA data

Every field from FDA enforcement report D-1063-2020, exactly as published.

Show all FDA fields
City
Berlin
State
CT
Status
Terminated
Country
United States
Event ID
85054
Address
15 Massirio Dr Ste 201
Code information
Lot # 5553.044E; 5553.044F, Exp. 04/30/2021
Postal code
06037-2352
Report date
Mar 4, 2020
Product type
Drugs
Recall number
D-1063-2020
Classification
Class III
Recalling firm
Breckenridge Pharmaceutical, Inc
Product quantity
900 Vials
Termination date
Aug 31, 2020
Reason for recall
Failed Impurities/Degradation Specifications: Out-of-specification results obtained for impurities during stability testing.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Zoledronic Acid Injection 5 mg/100 mL (0.05 mg/mL), Solution for Intravenous Infusion, Sterile Solution, 100 mL Single - Dose Vial per Carton, Rx Only, Distributed by: Breckenridge Pharmaceutical, Inc., Boca Raton, FL 33487, Manufactured by: Pharmaceutics International, Inc., Hunt Valley, MD 21031, NDC 51991-064-98.
Distribution pattern
Nationwide in the U.S.
Recall initiation date
Feb 24, 2020
Initial firm notification
Letter
Center classification date
Mar 25, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1063-2020, published Mar 4, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls